Medicine
Cosyntropin 0.25 mg/mL powder for injection
Cosyntropin 0.25 mg/mL powder for injection is a generic prescription medicine for intramuscular, intravenous, parenteral use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20º to 25ºC (68º to 77ºF), excursions permitted between 15° to 30°C…
Key facts
- Active ingredient (INN)
- Cosyntropin
- Brand
- Sold under the generic name
- Strength
- 0.25 mg/mL
- Dosage form
- Powder for injection
- Route
- Intramuscular, intravenous, parenteral
- Packs
- 1 vial
- Manufacturer
- Henry Schein
- Origin register
- US FDA, United States
- Storage
- Store at 20º to 25ºC (68º to 77ºF), excursions permitted between 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- H01AA02 Cosyntropin
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 January 2022
- Identifiers
- DailyMed set ID 0c424fac-b114-41f6-aba8-cf710a34c26cNDC 0404-9839Application NDA016750
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial in 1 bag / 1 mL in 1 vial | 0404-9839-99 | Henry Schein | 9 January 2022 |
| 10 vial in 1 carton / 1 mL in 1 vial | 0781-3440-95 | — | 29 June 2012 |
| 1 mL in 1 vial | 51662-1567-1 | — | 10 July 2021 |
| 1 vial in 1 bag / 1 mL in 1 vial | 71872-7313-1 | — | 6 October 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 22 April 1970 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Cosyntropin 0.25 mg/mL powder for injection.
Clinical summary
Cosyntropin is an adrenocorticotropic hormone indicated , in combination with other diagnostic tests, for use as a diagnostic agent in the screening of adrenocortical insufficiency in adults and pediatric patients. MedsAcross supplies Cosyntropin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CosyntropinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cortrosyn prescribing information (Amphastar Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Cosyntropin 0.25 mg/mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.